The US Food and Drug Administration has approved a new combination oral contraceptive from Bayer Schering Pharma AG that contains a folate (levomefolate calcium), in order to protect against neural tube defects during a pregnancy. ---Subscribe to MedNous to access this article--- Regulation & Policy Company News
